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An early single-center experience of portal vein 
thrombosis in living donor liver transplantation: 
clinical feature, management and outcome
Joo Dong Kim, Dong Lak Choi, Young Seok Han
Division of Hepatobiliary and Transplantation Surgery, Department of Surgery, Catholic University of Daegu School of Medicine, 
Daegu, Korea
Purpose: Portal vein thrombosis (PVT) has been considered a relative contraindication for living donor liver transplantation 
(LDLT). However, it is no longer a contraindication of LDLT due to improvement in surgical techniques and approaches to 
PVT. The aim of this study was to assess the impact of PVT on outcomes in LDLT patients. Methods: We retrospectively ana-
lyzed the data from 97 adult patients undergoing LDLT in our center from July 2008 to June 2010. Intraoperative findings and 
preoperative imaging results were reviewed for PVT grading (Yerdel grading). We analyzed the technical aspects and com-
parisons of risk factors, perioperative variables, and survivals between patients with and without PVT based on the grades. 
Results: In the 97 LDLT patients, 18 patients were confirmed to have PVT (18.5%) including grade I cases (n = 8), grade II (n = 
7), and grade III (n = 3). Prior treatment of portal hypertension was found to be an independent risk factor for PVT (P = 0.001). 
The comparisons between PVT and no PVT groups showed no significant difference in intraoperative and postoperative var-
iables except for postoperative bleeding (P = 0.036). The short-term portal vein patency, in-hospital mortality and survival 
rates were not significantly different between the PVT and control groups. Conclusion: The outcomes are similar to non-PVT 
group in terms of in-hospital mortality, survival rates, and postoperative complications. Therefore, our study suggests that 
PVT cannot be considered to be a contraindication for LDLT and LDLT could be undertaken without increased morbidity 
and mortality in patients with PVT, in spite of operative complexity.
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INTRODUCTION
In the early period of liver transplantation (LT), portal 
vein thrombosis (PVT) was considered a contraindication 
for operation because of the technical difficulties it en-
tailed, especially the inability to gain an adequate portal 
supply [1-3]. In 1985, Shaw et al. [4] reported the first suc-
cessful deceased donor liver transplantation (DDLT) for a 
PVT patient and since then, many innovative surgical 
techniques have been introduced such as thrombectomy, 
portal vein (PV) reconstruction using vein grafts, and cav-
oportal hemitransposition [5-9]. Current PVT patients are 
no longer regarded to be contraindicated for LT and the re-
sults for patients with PVT is now comparable to that of Joo Dong Kim, et al.
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patients without PVT [1,2,9,10]. Nevertheless, PVT is con-
sidered to add high risk to LT because of the complexity of 
LT procedures, resulting in significant surgical morbidity 
and mortality [10,11].
In living donor liver transplantation (LDLT), the issue 
of subjecting a healthy donor to potentially significant 
morbidity and mortality has led to a critical reassessment 
of the recipient selection criteria that are considered ac-
ceptable in DDLT [12]. In addition, there are some techni-
cal difficulties due to these innovations for preexisting 
PVT patients; necessity of distal dissection of vascular 
pedicle of the hilum and restricted availability of deceased 
donor vein graft [10,11].
Therefore, based on greater technical difficulties and 
the results from DDLT in this group of patients, the pres-
ence of PVT has often been considered to be a relative or 
absolute contraindication in LDLT [13,14].
From this point of view, the purpose of this report is to 
analyze single-center experiences in management of PVT, 
and to assess the impact of PVT on the outcomes in adult 
LDLT patients.
METHODS
We retrospectively studied the records of 97 LDLT pa-
tients using data collected prospectively among 109 cases 
of consecutive adult LDLT performed at our center from 
July 2008 to June 2010. In our center, PVT has not been a 
contraindication for LDLT except where the preoperative 
radiologic studies demonstrate a gross tumor thrombus in 
the main portal vein. All PVT patients were diagnosed us-
ing abdominal computed tomography (CT) performed 
within 3 months before transplantation, and intra-
operative detection. For standardization purposes, 12 pa-
tients were excluded for the following reasons: 1) no avail-
ability of preoperative and postoperative CT scans, 2) in-
sufficient records of the intraoperative findings, or 3) tu-
mor thrombus confirmed by postoperative pathology.  
PV flow was monitored routinely after transplantation 
by Doppler ultrasound at post-transplant days 1,4, and 7, 
and dynamic CT scan at days 14 and 21.
PVT was diagnosed preoperatively and/or intra-
operatively in 18 cases (18.5%). These patients with pre-
operatively and/or intraoperatively confirmed PVT formed 
the study group. Patients without PVT and transplanted 
during the same period were used as the control group.
All patients with confirmed PVT were retrospectively 
classified into four grades according to the extent of 
thromboses, as described by Yerdel et al. [15]: Grade I: 
minimally or partially thrombosed PV, in which the 
thrombus is mild or, at the most, confined to ＜50% of the 
vessel lumen with or without minimal extension into the 
superior mesenteric vein (SMV). Grade II showed ＞50% 
occlusion of the PV, including total occlusion with or with-
out minimal extension into the SMV. Grade III were com-
plete thromboses of both PV and proximal SMV with an 
open distal SMV. Grade IV was complete thrombosis of the 
portal vein as well as the proximal and distal SMV.
The preoperative, intraoperative, and postoperative pa-
rameters in these two groups were compared. The patients 
with PVT and those with non-PVT were followed up for a 
median time of 15.3 months (range, 1.2 to 36.5 months) and 
14.9 months (range, 2.4 to 36.3 months).
Assessment of risk factors for PVT and outcomes 
analysis 
Analyzed potential risk factors for PVT included; age, 
sex, primary disease or Child-Turcott-Pugh (CTP) score, 
the average model for end-stage liver disease (MELD) 
sore, preoperative platelet count, preoperative pro-
thrombin time, living donor characteristics, quality of do-
nated liver, previous treatment for portal hypertension 
(splenectomy, shunt operation, transjugular intrahepatic 
portosystemic shunt [TIPS], or sclerotherapy), and pres-
ence of malignancy. 
Surgery time, amount of operative red blood cell (RBC) 
transfusion, duration of hospital and intensive care unit 
(ICU) stays were analyzed. Postoperative complications 
(postoperative bleeding, biliary complication, PVT or 
stenosis, hepatic artery complication, infection, rejection) 
were compared. In-hospital mortality and patient survival 
were compared according to the presence of PVT.
Statistical analysis 
Continuous variables are represented as a mean ± SD An early single-center experience of portal vein thrombosis in living donor liver transplantation
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Table 1. Recipient, donor, and graft characteristics of LDLT in patients with and without PVT
PVT (n = 18) Non-PVT (n = 79) P-value
Age (yr) 50.8 ± 7.3 50.5 ± 8.2 0.791
Recipient gender (M:F) 14:4 57:22 0.627
Primary disease
HBV/HCV related liver cirrhosis without HCC 9 (50.0) 28 (35.4) 0.289
HBV/HCV related liver cirrhosis with HCC 5 (27.8) 31 (39.2) 0.428
Alcoholic liver cirrhosis  2 (11.1) 12 (15.2) 0.99
Others
a)  2 (11.1) 8 (10.2) 0.99
CTP score  9.1 ± 1.8 8.7 ± 2.8 0.620
MELD score 17.3 ± 8.1 17.7 ± 10.3 0.831
Ascites (mL) 1,261.1 ± 1,440.2 1,383.5 ± 1,892.8 0.964
Preoperative platelet (×10
3/μL) 55.1 ± 31.3 68.9 ± 27.7 0.243
Preoperative prothrombin time (INR) 1.88 ± 0.63 1.92 ± 0.88 0.639
Previous treatment of portal HTN (Y:N) 6:12 5:74 0.014
Donor age (yr) 30.0 ± 7.7 27.7 ± 7.9 0.238
Donor gender (M:F) 10:9 58:22 0.159
Graft fatty change (%) 1.11 ± 3.66 2.72 ± 5.23 0.111
Graft-to-recipient weight ratio (%) 0.98 ± 0.19 1.06 ± 0.25 0.151
Type of graft
Single (right/left liver) 13:4  70:8 0.129
Dual 1 1 0.338
Values are presented as mean ± SD or number (%).
LDLT, living donor liver transplantation; PVT, portal vein thrombosis; HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular
carcinoma; CTP, Child-Turcott-Pugh; MELD, the average model for end-stage liver disease; INR, international normalized ratio; HTN, 
hypertension; Y, yes; N, no. 
a)Cryptogenic liver cirrhosis, fulminent hepatic failure, primary biliary cirrhosis.
and categorical data were analyzed using the Fisher’s ex-
act test. A Mann-Whitney U test was used to compare the 
group means. The Kaplan-Meier method was used to es-
timate survival curves, and survival curves were com-
pared by means of the log-rank test. All analyses were 
carried out using SPSS ver. 14.0 (SPSS Inc., Chicago, IL, 
USA). A P-value less than 0.05 was considered 
significant.
RESULTS
Incidence and grading of PVT 
PVT was diagnosed in 18 of the total 97 adult patients 
(18.5%) who underwent LDLT including 8 cases (44.4%) of 
grade I; 7 (38.9%) of grade II; 3 (16.7%) of grade III. 
Preoperative risk factors for PVT (Table 1)
Age, gender, primary disease, CTP score, MELD score, 
presence of hepatocellular carcinoma (HCC), ascites, pre-
operative platelet count, and prothrombin time showed 
no relationship to PVT (P ＞  0.05). Living donor character-
istics and quality of donated liver had no significant differ-
ences between the two groups. However, previous treat-
ment of portal hypertension (splenectomy, shunt oper-
ation, TIPS, sclerotherapy) was associated with PVT (P = 
0.014).
Intraoperative and postoperative variables be-
tween PVT and non-PVT groups (Table 2)
The mean duration of operation in the patients with 
PVT (598.2 ± 115.4 minutes) was longer than in those with-
out PVT (572.6 ± 97.6 minutes), but this was not statisti-
cally significant (P = 0.483). The overall mean RBC trans-
fusion requirement in the patients with PVT (1,018.2 ± 
816.2 mL) was not significantly different to that in those 
without PVT (1,203.7 ± 1,021.7 mL, P = 0.485). The mean 
ICU stay was similar in both groups (4.47 ± 1.12 days vs. 
5.32 ± 5.6 days, P = 0.632). The mean hospital stay was also 
similar (32.2 ± 11.6 days vs. 34.5 ± 23.1 days, P = 0.612). Joo Dong Kim, et al.
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Table 2. Comparative analysis of operative and postoperative variables with or without PVT
PVT (n = 18) Non-PVT (n = 79) P-value
Operation time (min)  598.2 ± 115.4  572.7 ± 97.6 0.483
RBC transfusion (mL) 1,018.2 ± 816.2 1,203.7 ± 1,021.7 0.485
ICU stay (day)    4.47 ± 1.18   5.32 ± 5.64 0.632
Admission stay (day)  32.24 ± 11.61  34.52 ± 23.06 0.612
Postoperative complications (%) 
Postoperative bleeding   22.2   6.3 0.049
Biliary complication  (biliary stricture, bile leak)  27.8   21.5 0.529
Infection (regardless type)  16.1   10.1 0.405
Portal vein complication (stenosis, rethrombosis)   5.6   2.5 1.000
Hepatic artery complication (stenosis, thrombosis)   0   5.1 0.582
Rejection   5.6   1.3 0.324
PVT, portal vein thrombosis; RBC, red blood cell; ICU, intensive care unit.
Fig. 1. Survival curves in the portal vein thrombosis (PVT) and non-PVT groups (A), and in the PVT and non-PVT groups after excluding 
malignancy (B). 
Postoperative complications of PVT patients (Table 2)
The incidence of postoperative bleeding in the patients 
with PVT was significant higher than in those without 
PVT (22.2% vs. 6.3%, P = 0.049). But, the rate of portal vein 
rethrombosis or stenosis, hepatic artery complication, in-
fection, biliary complication (bile leak, biliary stricture), 
and rejection were similar in the PVT and non-PVT 
groups. 
PV patency and patient’s survival of PVT group
The PV patency of the PVT group in their follow-up pe-
riod was similar to the non-PVT group. Only one of the pa-
tients with PVT developed a rethrombosis. A relapar-
otomy and intraoperative PV stenting were performed at 
the 13th day after transplantation. 
The in-hospital mortality for patients with PVT was 
similar to that of patients without PVT (5.6% vs. 3.8%, P 
= 0.548). The 1-and 3-year actuarial survival rate in the 
PVT group were 87.7% and 75.2%, respectively, but 
there was no statistical difference between the PVT 
group and the non-PVT groups (log-rank test, P = 0.357) 
(Fig. 1A). 
Considering the influence of HCC on survival, we ex-
cluded patients with cancer from both groups, leaving 36 
patients in the PVT group and the controls, still there was 
no significant difference between the two groups 
(log-rank test, P = 0.979) (Fig. 1B).An early single-center experience of portal vein thrombosis in living donor liver transplantation
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Table 3. Surgical procedures for thrombectomy and reconstruction as grade
Grade No. Treatment Outcome
I 8 Simple thrombectomy (n = 3) IOP PV stent (n = 1)
Eversion thrombectomy (n = 3)
II 7 Eversion thrombectomy (n = 6) Uneventful
PV reconstruction with interposition graft (n = 1)
III 3 Eversion thrombectomy (n = 1) Uneventful
PV reconstruction with interposition graft/PV stent (n = 1)
RP-A (n = 1)
IOP, intraoperative; PV, portal vein; RP-A, renoportal anastomosis. 
Fig. 2. Portal vein (PV) reconstruction with interposition vein graft in case of failed eversion thrombectomy. Preoperative computed 
tomography (CT) scan of this case showed that portal vein is completely obstructed (white arrow) and PV thrombosis propagated to 
portomesenteric junction (A). Interposition vein graft was used for portal vein reconstruction (B) and intraoperative PV stenting (black arrow)
was performed due to residual thrombus (C). Patency of interposition graft was demonstrated by postoperative CT scan (D).
Operative management 
Surgical management of PVT was dependent on the 
characteristics of the thrombus; its size (partial or com-
plete) or extension degree through the portal venous 
system. Surgical procedures for PVT are shown in Table 3.
Most patients with grade I and II thrombosis were man-Joo Dong Kim, et al.
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Fig. 3. Portal vein (PV) reconstruction with renoportal anas-
tomosis. Abdominal computed tomography (CT) scan showed 
complete portal vein thrombosis extended to proximal superior 
mesenteric vein (arrow) and marked dilated splenorenal shunt 
drained into the left renal vein (arrow head) (A). Interposition graft 
was anastomosed to upper border of left renal vein and the graft PV 
is anastomosed to proximal end of the interposition graft (B). No 
signs of portal vein system stenosis were visible in postoperative 
abdominal CT scan (C).
aged with classic PV-PV anastomosis with or without sim-
ple thrombectomy or eversion thrombectomy. In only one 
patient with grade II, an interposition iliac vein graft was 
used as anastomosis between the donor’s PV to the recipi-
ent’s proximal portal vein nearby the spleno-portal junc-
tion because the hilum had severe fibrotic change due to a 
previous hepatectomy where the thromboses were not 
completely removed. 
One patient with grade III thrombosis was successfully 
treated with eversion thrombectomy after lower dis-
section and classic PV-PV anastomosis. However, the oth-
er two cases failed complete eversion thrombectomy, and 
had no suitable PV to perform the classic anastomosis. In 
one of these cases, interposition iliac vein graft was used 
for PV reconstruction. And, in addition, intraoperative PV 
stenting was performed because there was residual 
thrombus at the spleno-mesenteric junction and proximal 
SMV (Fig. 2).
In the other case with complete and extended occlusion 
of the SMA and a large splenorenal shunt, renoportal anas-
tomosis was performed in a side-to-end fashion (Fig. 3).
DISCUSSION 
The PVT is a well-established complication among pa-
tients with end-stage liver disease, and its incidence rang-
es from 2 to 26% in various centers [8,14], reaching as high 
as 39% in certain patient populations [16]. The incidence of 
PVT in LDLT patients at our center was 18.5%.
The etiology is not completely understood, but is be-
lieved to be related to anatomic change in the liver owing An early single-center experience of portal vein thrombosis in living donor liver transplantation
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to the cirrhotic process, increased portal pressure, endo-
thelial injury or coagulation changes [1,15,17,18]. In past 
studies, high-risk factors for developing PVT included au-
toimmune hepatitis, cryptogenic cirrhosis, chronic active 
hepatitis, Budd-Chiari syndrome, male gender, increased 
age, trauma, hypercoagulative states, Child-Pugh C, and 
treatment of portal hypertension (splenectomy, shunt op-
eration, TIPS) [4,14,15,19]. But, this study found that pre-
vious treatment of portal hypertension was an in-
dependent risk factor for PVT prior to LDLT. 
PVT was considered for 2 decades to be an absolute con-
traindication for LT [17]. However, in 1985, two successful 
liver transplantations were reported despite PVT [4]. Since 
then, progress in LT has allowed surgeons to utilize multi-
ple techniques including thrombectomy of native veins, 
extensive thromboendovenectomy up to splenomesen-
teric confluence, venous interposition graft, renoportal 
anastomosis, cavoportal hemitransposition for over-
coming this major problem and restoring PV flow 
[6,15,20,21]. But, there are some problems with technical 
difficulties and restricted availability of vein graft in LDLT 
as of yet [10,11,18]. The ideal surgical technique to resolve 
PVT during LT is not defined. The treatment depends on 
the characteristics of thrombosis (whether acute or chron-
ic), degree (partial or complete), and especially, degree of 
extension to the splanchnic venous system [1,17].
In our study, 93.3% (n = 14) of patients with grade I and 
II PVT were successfully managed by classic PV-PV anas-
tomosis with or without simple or eversion throm-
bectomy. In only one patient with grade II PVT, we per-
formed thrombosed PV resection and portal vein re-
construction using interposition vein graft between the 
donor’s PV and the recipient’s proximal PV close to sple-
no-portal junction because of severe porta hepatis fibrotic 
change and incomplete eversion thrombectomy.
In one grade III PVT patient eversion thrombectomy 
failed, interposition vein graft was used and intra-
operative PV stenting was performed due to residual 
thrombus at portomesenteric confluence level. And in the 
other case of grade III PVT with large splenorenal shunt, 
we experienced portal vein reconstruction using an inter-
position iliac vein graft connected to the left renal vein in a 
side-to-end fashion.
Regarding to blood transfusion, operation time, and 
in-hospital stay including ICU stay, no statistical differ-
ence was observed between the PVT and non-PVT groups 
in our study, indicating that proper management of PVT is 
a controllable procedure of LDLT.
The greater technical difficulty in patients with pre-ex-
isting PVT has demonstrated an increased risk of compli-
cations like hepatic artery thrombosis, relaparotomy, post-
operative pancreatitis, sepsis, and renal failure in the dif-
ferent studies [9,15,22]. In our center, comparisons of the 
PVT patients and controls showed no statistical differ-
ences except postoperative bleeding. This increased risk is 
related to pre-existing PV pathology, high blood loss, the 
development of coagulopathy and severe acidosis [23]. 
Therefore, meticulous operative procedures and close 
monitoring for postoperative bleeding are required. 
Initially, patients with PVT undergoing LT showed a 
high mortality rate in some papers [24]. But, recent studies 
such as that of Lladó et al. [25] have described similar sur-
vival in patients with PVT compared to patients without 
PVT. In our study, the results (in-hospital mortality, 1-and 
3-year survival rates) obtained in patients undergoing 
LDLT with preoperative PVT are not significantly differ-
ent to patients without PVT, despite short-term follow-up. 
Moreover, PVT of grade II to III can be managed with dif-
ferent techniques, with good postoperative results. The re-
sults suggest that accurate preoperative evaluation and 
detailed surgical planning are essential for restoring PV 
patency in LDLT patients.
In conclusion, the results are similar to non-PVT group 
in terms of in-hospital mortality, survival rates, and post-
operative complications, and PV patency. Therefore, our 
experience suggests that PVT cannot be considered to be a 
contraindication for LDLT in spite of operative com-
plexity.  
In PVT of grade II and III, LDLT could be undertaken 
successfully with accurate preoperative diagnosis and 
proper surgical techniques and good postoperative out-
comes can be obtained. Furthermore, innovations of ther-
apeutic approaches and accumulation of experience could 
be required to improve the outcomes in LDLT with the 
more extensive PVT patients.Joo Dong Kim, et al.
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